Stocks
Haemonetics Corporation (HAE) EBITDA US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 191.7 | 252.0 | 295.5 | 356.0 | 312.4 | 337.6 | ||
| Changes by years, y/y, % | +4% | +31% | +17% | +20% | -12% | +11.1% | |||
Haemonetics Corporation. EBITDA US GAAP, bln rub
Haemonetics Corporation. EBITDA US GAAP, changes, %
Haemonetics Corporation. EBITDA US GAAP, sum by quarters, bln rub
Haemonetics Corporation (HAE) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 79.7 | 93.7 | 86.8 | 95.5 | 4.29 | 337.6 | |
| Changes by years, y/y, % | +16% | +17% | -3% | +0% | -95% | |||
| Changes by quarters, q/q, % | -16% | +18% | -7% | +10% | -96% | |||
